Loading...

Krystal Biotech, Inc. Peer Comparison

Metric Value Ranking
Market Cap $4.4 Billion 1/6 KRYS
$4.4B
APLS
$3.5B
RYTM
$3.5B
DCPH
$2.2B
MGTX
$503.3M
RGNX
$356.7M
Gross Margin 90% 2/6 DCPH
92%
KRYS
90%
RYTM
88%
APLS
81%
RGNX
49%
MGTX
-10%
Profit Margin 32% 1/6 KRYS
32%
APLS
-33%
RGNX
-100%
DCPH
-100%
RYTM
-100%
MGTX
-100%
EBITDA margin 27% 1/6 KRYS
27%
APLS
-38%
DCPH
-105%
RYTM
-132%
RGNX
-257%
MGTX
-367%
Quarterly Revenue $83.8 Million 2/6 APLS
$176.6M
KRYS
$83.8M
DCPH
$45.0M
RYTM
$33.3M
RGNX
$24.2M
MGTX
$10.9M
Quarterly Earnings $27.2 Million 1/6 KRYS
$27.2M
MGTX
-$39.3M
RYTM
-$45.0M
DCPH
-$45.1M
APLS
-$57.4M
RGNX
-$59.6M
Quarterly Free Cash Flow $57.8 Million 1/6 KRYS
$57.8M
APLS
$34.1M
RYTM
$14.8M
MGTX
-$22.0M
RGNX
-$40.9M
DCPH
-$54.7M
Trailing 4 Quarters Revenue $241.5 Million 2/6 APLS
$675.9M
KRYS
$241.5M
DCPH
$174.9M
RYTM
$112.5M
RGNX
$84.3M
MGTX
$13.9M
Trailing 4 Quarters Earnings $52.4 Million 1/6 APLS
$176.6M
KRYS
$83.8M
DCPH
$45.0M
RYTM
$33.3M
RGNX
$24.2M
MGTX
$10.9M
Quarterly Earnings Growth 182% 1/6 KRYS
182%
APLS
59%
MGTX
11%
RGNX
4%
DCPH
2%
RYTM
-2%
Annual Earnings Growth 133% 1/6 KRYS
133%
APLS
51%
MGTX
34%
RGNX
14%
DCPH
-4%
RYTM
-41%
Quarterly Revenue Growth 0% 5/6 MGTX
114%
APLS
78%
RYTM
48%
DCPH
35%
KRYS
0%
RGNX
-16%
Annual Revenue Growth 0% 5/6 MGTX
173%
APLS
76%
RYTM
40%
DCPH
23%
KRYS
0%
RGNX
-5%
Cash On Hand $374.0 Million 2/6 APLS
$396.9M
KRYS
$374.0M
MGTX
$122.9M
DCPH
$91.2M
RGNX
$56.6M
RYTM
$47.5M
Short Term Debt $1.3 Million 5/6 RGNX
$7.7M
APLS
$6.8M
MGTX
$4.2M
DCPH
$3.6M
KRYS
$1.3M
RYTM
-$0
Long Term Debt $0 5/6 APLS
$104.7M
RGNX
$76.3M
DCPH
$21.4M
RYTM
$4.0M
KRYS
$0
MGTX
$0
PE 83.10 1/6 KRYS
83.10
RGNX
-1.00
APLS
-1.00
DCPH
-1.00
RYTM
-1.00
MGTX
-1.00
PS 18.02 3/6 MGTX
36.13
RYTM
31.45
KRYS
18.02
DCPH
12.65
APLS
5.25
RGNX
4.23
PB 4.91 5/6 RYTM
23.17
APLS
14.96
DCPH
7.00
MGTX
5.26
KRYS
4.91
RGNX
1.18
PC 11.64 3/6 RYTM
74.47
DCPH
24.26
KRYS
11.64
APLS
8.94
RGNX
6.30
MGTX
4.10
Liabilities to Equity 0.11 6/6 RYTM
18.80
APLS
2.80
MGTX
2.13
RGNX
0.72
DCPH
0.33
KRYS
0.11
ROA 0.05 1/6 KRYS
5%
APLS
-28%
MGTX
-29%
DCPH
-45%
RGNX
-46%
RYTM
-72%
ROE 0.06 1/6 KRYS
6%
DCPH
-60%
RGNX
-79%
MGTX
-92%
APLS
-105%
RYTM
-2320%
Current Ratio 10.18 1/6 KRYS
10.18
DCPH
4.01
RGNX
2.38
RYTM
1.72
MGTX
1.47
APLS
1.36
Quick Ratio 6.10 1/6 KRYS
83.10
RGNX
-1.00
APLS
-1.00
DCPH
-1.00
RYTM
-1.00
MGTX
-1.00
Long Term Debt to Equity 0.00 5/6 APLS}
0.44
RYTM}
0.36
RGNX}
0.25
DCPH}
0.07
KRYS}
0.00
MGTX}
0.00
Debt to Equity 0.00 6/6 APLS
0.47
RYTM
0.36
RGNX
0.28
DCPH
0.08
MGTX
0.04
KRYS
0.00
Burn Rate -13.92 6/6 APLS
6.27
MGTX
3.04
DCPH
1.95
RYTM
1.05
RGNX
0.88
KRYS
-13.92
Cash to Cap 0.09 4/6 MGTX
0.24
RGNX
0.16
APLS
0.11
KRYS
0.09
DCPH
0.04
RYTM
0.01
CCR 2.13 1/6 KRYS
2.13
DCPH
1.21
RGNX
0.69
MGTX
0.56
RYTM
-0.33
APLS
-0.59
EV to EBITDA 177.39 1/6 KRYS}
177.39
RGNX}
-6.19
MGTX}
-9.61
DCPH}
-45.43
APLS}
-48.28
RYTM}
-79.64
EV to Revenue 16.48 3/6 RYTM
31.06
MGTX
27.61
KRYS
16.48
DCPH
12.27
APLS
4.82
RGNX
4.56